Individualized Phenytoin Therapy for Japanese Pediatric Patients With Epilepsy Based on CYP2C9 and CYP2C19 Genotypes-Reference-Cited by-同舟云学术

Individualized Phenytoin Therapy for Japanese Pediatric Patients With Epilepsy Based on CYP2C9 and CYP2C19 Genotypes

Published:2015-04 Issue:2 Volume:37 Page:229-235
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Yamamoto Yoshiaki,Takahashi Yukitoshi,Imai Katsumi,Miyakawa Kou,Ikeda Hiroko,Ueda Yuki,Yamaguchi Tokito,Nasu Hirosato,Ohtani Hideyuki,Shigematsu Hideo,Kagawa Yoshiyuki,Inoue Yushi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. . Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.;Patsalos;Epilepsia,2008

2. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.;Schmidt;Neurology,1984

3. . Effect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.;Hashimoto;Biol Pharm Bull,1996

4. . Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolite.;Bajpai;Drug Metab Dispos,1996

5. . The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.;Mamiya;Epilepsia,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs;JAMA Network Open;2024-08-08

2. Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study;International Journal of Antimicrobial Agents;2024-05

3. Fosphenytoin dosing regimen including optimal timing for the measurement of serum phenytoin concentration in pediatric patients;Brain and Development;2022-11

4. A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters;Pharmacogenomics;2021-07

5. Human total clearance values and volumes of distribution of typical human cytochrome P450 2C9/19 substrates predicted by single-species allometric scaling using pharmacokinetic data sets from common marmosets genotyped for P450 2C19;Xenobiotica;2021-01-17